A comparative trial of praziquantel, metrifonate and niridazole against Schistosoma haematobium.

Praziquantel administered in a single oral dose of 30 mg kg-1 to subjects infected with Schistosoma haematobium produced minimal side effects and was more effective than established regimes of niridazole and metrifonate. Praziquantel should prove a major tool in schistosomiasis control programmes.

RCT Entities:   Population Interventions Outcomes